This statistic shows the annual revenue of Sino Biopharmaceutical Limited from 2013 to 2022. In 2022, Sino Biopharm's annual revenue amounted to approximately 28.8 billion yuan, up from 26.9 billion yuan in the previous year.
Annual revenue of Sino Biopharmaceutical from 2013 to 2022
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sino Biopharmaceutical. (April 28, 2023). Annual revenue of Sino Biopharmaceutical from 2013 to 2022 (in billion yuan) [Graph]. In Statista. Retrieved December 22, 2024, from https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/
Sino Biopharmaceutical. "Annual revenue of Sino Biopharmaceutical from 2013 to 2022 (in billion yuan)." Chart. April 28, 2023. Statista. Accessed December 22, 2024. https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/
Sino Biopharmaceutical. (2023). Annual revenue of Sino Biopharmaceutical from 2013 to 2022 (in billion yuan). Statista. Statista Inc.. Accessed: December 22, 2024. https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/
Sino Biopharmaceutical. "Annual Revenue of Sino Biopharmaceutical from 2013 to 2022 (in Billion Yuan)." Statista, Statista Inc., 28 Apr 2023, https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/
Sino Biopharmaceutical, Annual revenue of Sino Biopharmaceutical from 2013 to 2022 (in billion yuan) Statista, https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/ (last visited December 22, 2024)
Annual revenue of Sino Biopharmaceutical from 2013 to 2022 (in billion yuan) [Graph], Sino Biopharmaceutical, April 28, 2023. [Online]. Available: https://www.statista.com/statistics/940190/hong-kong-sino-biopharm-annual-revenue/